IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.36 -0.45 (-1.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

IDEAYA Biosciences (IDYA) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

IDEAYA Biosciences (IDYA) recorded Return on Capital Employed [ROCE] of -19.95% in Q2 2026, up 17.88 percentage points from -37.83% a year earlier but down 1.70 percentage points from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, IDEAYA Biosciences reported Return on Capital Employed [ROCE] of -15.06%, up 23.84 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +6.11 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -38.90% in FY2024 (-11.55 pp), -27.35% in FY2023 (-9.64 pp), -17.71% in FY2022 (-0.65 pp) and -17.06% in FY2021 (+4.10 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -37.83% in Q2 2025 to -11.43% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for four consecutive quarters, with an average year-over-year change of +1.96 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 17.88 percentage points in Q2 2026, against a drop of 17.18 percentage points in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -18.26% (Q1 2026), -14.64% (Q4 2025) and -19.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 IDEAYA Biosciences 3.60 Bn 674.16 Mn - -19.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.95%
Mar 31, 2026 -18.26%
Dec 31, 2025 -14.64%
Sep 30, 2025 -19.92%
Jun 30, 2025 -37.83%
Mar 31, 2025 -33.95%
Dec 31, 2024 -28.79%
Sep 30, 2024 -21.08%
Jun 30, 2024 -20.65%
Mar 31, 2024 -20.39%
Dec 31, 2023 -23.83%
Sep 30, 2023 -23.54%
Jun 30, 2023 -20.14%
Mar 31, 2023 -21.52%
Dec 31, 2022 -17.00%
Sep 30, 2022 -15.93%
Jun 30, 2022 -23.01%
Mar 31, 2022 -17.68%
Dec 31, 2021 -14.56%
Sep 30, 2021 -11.43%
API Access

IDEAYA Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IDYA&period=max&api_key=YOUR_API_KEY